02:53 PM EDT, 08/13/2025 (MT Newswires) -- Alcon ( ALC ) is expected to report higher-than-expected revenue but earnings per share in line with estimates for Q2 on Aug. 19, driven by mid-single-digit year-over-year sales growth and favorable currency effects, Needham said Wednesday in a report.

Needham anticipates the eyecare company to raise its full-year guidance, supported by strong momentum in premium vision care segments, including AT-IOLs, prescription glaucoma treatments, and contact lenses.

Forthcoming product launches, such as the Precision 7 lens and PanOptix Pro, together with recent deals like the planned acquisitions of STAAR and LENSAR, are expected to bolster growth prospects, Needham said.

The firm maintained its buy rating on the stock, with a price target of $107.

Price: 86.58, Change: +0.55, Percent Change: +0.64